Watch Ticker

Monte Rosa Therapeutics, Inc. Common Stock

Go to Monte Rosa Therapeutics, Inc. Common Stock Website

$4.83

0.00 (0.00%)

Live

Previous Close

$4.83

Day Range

$0 - $0

Previous Day Range

$4.78 - $4.935

Market Cap

$300.2 million USD

Day Vol.

Previous Day Vol.

294271

Currency

USD

Primary Exchange

Nasdaq

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutica...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Monte Rosa Therapeutics - Monte Rosa Therapeutics Announces First Subjects Dosed in Phase 1 Study of MRT-8102, a NEK7-Directed Molecular Glue Degrader for the Treatment of Multiple Inflammatory Diseases

Monte Rosa Therapeutics initiated a Phase 1 clinical study for MRT-8102, a molecular glue degrader targeting NEK7 for treating inflammatory diseases. The study includes single and multiple ascending dose cohorts in healthy volunteers, with initial results expected in H1 2026.

Related tickers: GLUE, NVS, RHHBY.

Read Full Article

Monte Rosa Therapeutics - Monte Rosa Announces Publication in Science of Key Insights that Enable Next Generation Molecular Glue Degrader Medicines

Monte Rosa Therapeutics published groundbreaking research in Science, using AI and machine learning to expand the potential target space for molecular glue degrader medicines, identifying over 100 protein target classes previously considered undruggable.

Related tickers: GLUE, NVS, RHHBY.

Read Full Article

Trending Tickers

Please sign in to view